Skip to main content

Advertisement

Figure 3 | BMC Medicine

Figure 3

From: Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma

Figure 3

Disease specific (left) and overall (right) survival curves for kisspeptin and GPR54. The top two graphs demonstrate the significant survival curves for GPR54, while the middle two graphs demonstrate kisspeptin related survival. For the bottom two graphs, the p value refers to the distance between the GPR54 positive/kisspeptin positive cases (G+ K+, solid light grey) and the GPR54 negative/kisspeptin negative cases (G- K-, solid dark grey).

Back to article page